echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Acta Neuropathologica: The accumulation of end fragments of amyloid preloom protein C triggers mitochondrial structure, function, and filamentation defects in Alzheimer's models and the human brain.

    Acta Neuropathologica: The accumulation of end fragments of amyloid preloom protein C triggers mitochondrial structure, function, and filamentation defects in Alzheimer's models and the human brain.

    • Last Update: 2020-10-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Some recent evidence suggests that C-end fragments (APP-CTFs) derived from amyloid prescrotes proteins may be associated with the triggering of the pathogenesies of Alzheimer's disease (AD).
    in the mitochondrials is considered an early event in AD development.
    , the specific contribution of APP-CTFs to mitochondrial structure, function and silk splitting defects has yet to be confirmed.
    Here, we demonstrate that in neuroblastoma SH-SY5Y cells, the expression of APP Swedish mutations or β-secretase-derived APP-CTF fragments (C99) is combined with β and γ-secretase inhibition, and that the accumulation of APP-CTF is independent of excessive mitochondrial morphological changes triggered by A beta, which is associated with mitochondrial active oxygen enhancement.
    App-CTFs accumulation also causes basic silk splitting failure, which is manifested in the conversion enhancement of LC3, the accumulation of LC3-I and/or LC3-II, non-degradation of SQSTM1/p62, inconsistent collection of Parkin and PINK1 in mitochondrials, increased levels of membrane and substring mitochondrial proteins, and insufficient mitochondrial and lysosome fusion.
    We also confirmed that the accumulation of APP-CTFs had a impaired effect on the function of silk division in young 3xTgAD genetically modified mice treated with γ-secretase inhibitors, as well as in adeno-related virus C99 injected mice with morphological mitochondrial changes and fundamental silk division.
    2xTgAD and 3xTgAD older mice showed that, in addition to APP-CTFs, A-beta had an additional effect on the activation of late-stage silk division.
    , we reported that mitochondrial accumulation of APP-ctf in the human post-mortem AD brain was associated with molecular characteristics of silky splice failure.
    : Prepare total protein extract using lysate buffers (50 mM Tris pH 8, 10% glycerin, 200 mM NaCl, 0.5% Nonidet p-40, and 0.1 mM EDTA) with protease inhibitors added.
    the mitochondrial portion using a mixture of added protease inhibitors (250 mM D-Glycol, 5 mM HEPES pH 7.4, 0.5 mM EGTA, and 0.1% BSA).
    after freezing on ice for 20 minutes and frequently tapping, cells, mouse brains, or anatomic sea otters were crushed 120 times by glass homogenizers, centrifuged at 1500×g, 4 degrees C to remove unrecrupted cells and nuclei.
    collecting the liquid as the total fraction, the other part at 4 degrees C at 10000 × g centrifugation for 10 minutes to precipitate mitochondrial fractions, it suspended in a separation buffer with protease inhibitors added.
    full-length APP, APP-CTFs, and A-beta are separated on 16.5% trisine-SDS-PAGE and transferred to the cellulose nitrate membrane.
    the film in PBS, saturate it in TBS, 5% skimmed milk, and incubate overnight with specific antibodies.
    the rest of the proteins were separated by standard procedures for SDS-PAGE.
    above, mitochondrial steady-state defects play a key role in the pathogenesis of AD, so targeting mitochondrial dysfunction and/or devouration by inhibiting the accumulation of early APP-CTFs may be AD-related therapeutic interventions.
    Vaillant-Beuchot, L., Mary, A., Pardossi-Piquard, R. et al. Edgion o amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains. Acta Neuropathol (2020). MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.